Drugs / FluarixTM
FluarixTM
Trials 4
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 32 trials | ||||||
| Phase 3 | NCT01160237 | Aug 2010 → Feb 2011 | influenza | GlaxoSmithKline | Terminated | No outcome recorded |
| Phase 3 | NCT00866580 | May 2010 → Jul 2011 | influenza | GlaxoSmithKline | Withdrawn | No outcome recorded |
| Phase 42 trials | ||||||
| Phase 4 | NCT01190215 | Oct 2010 → Jul 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 4 | NCT00750360 | Oct 2003 → Dec 2007 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Comparator or background therapy4 trials | ||||||
| Phase 2 | NCT00385840 Comparator | Oct 2006 → Feb 2007 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01204671 Comparator | Oct 2010 → Jun 2011 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
| Phase 3 | NCT01196988 Comparator | Oct 2010 → Jun 2011 | influenza | GlaxoSmithKline | Completed | Met primary |
| Phase 3 | NCT00992784 Comparator | Oct 2009 → May 2010 | influenza | GlaxoSmithKline | Completed | No outcome recorded |
News releases announcing trial results or a regulatory action · 1
| Date | Issuer | Release |
|---|---|---|
| 2009-11-09 | GlaxoSmithKline | Results Pandemic 2009 Influenza Update: Pandemrix™ data on co-administration with annual seasonal influenza vaccine (Fluarix®) gsk.com ↗
The trial showed that co-administration of one dose of both vaccines in separate arms, induced a strong response in adults for both the H1N1 pandemic vaccine as well as the seasonal vaccine. |
All press releases naming this drug 3 releases
| Date | Issuer | Release |
|---|---|---|
| 2018-03-06 | GlaxoSmithKline | New clinical data demonstrate high vaccine efficacy of Fluarix Tetra (Influenza Vaccine) in children 6-35 months of age gsk.com ↗ |
| 2018-02-15 | GlaxoSmithKline | GSK receives European approval for expanded indication for Fluarix Tetra (Influenza Vaccine) for ages six months and older gsk.com ↗ |
| 2009-11-09 | GlaxoSmithKline | Pandemic 2009 Influenza Update: Pandemrix™ data on co-administration with annual seasonal influenza vaccine (Fluarix®) gsk.com ↗ |
Evidence & citations 5 cited values
Every value below carries the sentence it was read from. 8 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | FluarixTM | ClinicalTrials.gov intervention name — accepted as the source's own label NCT01160237 ↗ |
| Known as | FLUARIX | “GlaxoSmithKline Biologicals' Influenza Split Vaccine FLUARIX™ Administered According to the Prescribing Information” NCT00750360 ↗1“Subjects received one dose of the Fluarix™ vaccine at Day 0.” NCT01204671 ↗ |
| Known as | Influsplit SSW 2010/2011 | “Biological: FluarixTM/ Influsplit SSW® 2010/2011” NCT01160237 ↗ |
| Modality | Vaccine | “Fluarix™ vaccine” NCT00385840 ↗ |
| Route | Intramuscular | “Intramuscular dose on Day 42 or on Day -30, according to the vaccination schedule” NCT00866580 ↗ |